The therapeutic potential of RORγ modulators in the treatment of human disease

Mi Ra Chang,1 Devrishi Goswami,1 Becky A Mercer,2 Patrick R Griffin1,21Department of Molecular Therapeutics, Scripps Florida, The Scripps Research Institute, Jupiter, FL, USA; 2Translational Research Institute, Scripps Florida, The Scripps Research Institute, Jupiter, FL, USAAbstract: Nuclear recept...

Full description

Bibliographic Details
Main Authors: Chang MR, Goswami D, Mercer BA, Griffin PR
Format: Article
Language:English
Published: Dove Medical Press 2012-10-01
Series:Journal of Experimental Pharmacology
Online Access:http://www.dovepress.com/the-therapeutic-potential-of-rorgamma-modulators-in-the-treatment-of-h-a11266
_version_ 1818584148151894016
author Chang MR
Goswami D
Mercer BA
Griffin PR
author_facet Chang MR
Goswami D
Mercer BA
Griffin PR
author_sort Chang MR
collection DOAJ
description Mi Ra Chang,1 Devrishi Goswami,1 Becky A Mercer,2 Patrick R Griffin1,21Department of Molecular Therapeutics, Scripps Florida, The Scripps Research Institute, Jupiter, FL, USA; 2Translational Research Institute, Scripps Florida, The Scripps Research Institute, Jupiter, FL, USAAbstract: Nuclear receptors (NR) are ligand-regulated transcription factors that bind DNA in proximity to their target genes and exert their effects as a result of binding by small molecule ligands such as sterols, lipids, fatty acids, retinoids, and steroid hormones. The retinoic acid receptor-related orphan receptors or RORs (NR1F1–NR1F3) are nuclear receptors that regulate multiple cellular processes, including metabolism, cellular differentiation, and apoptosis, in a range of tissues and organs. These receptors bind as monomers to ROR response elements commonly called ROREs present in promoter regions of target genes and tether chromatin remodeling enzymes, facilitating recruitment of transcription machinery. Several recent reports have highlighted the potential role for RORs in human disease, and more importantly, studies have demonstrated that these receptors can be modulated by exogenous synthetic ligands, paving the way for development of novel therapeutics. Here we review the current status of synthetic ligand development as well as the structural aspects governing modulation of ROR signaling pathways as they relate to metabolic diseases and autoimmune disorders.Keywords: retinoic acid receptor-related orphan receptors (ROR), nuclear receptor (NR)modulator, synthetic ligand, inverse agonists, metabolic disorder, autoimmune disorder, ligand-binding domain (LBD)
first_indexed 2024-12-16T08:16:34Z
format Article
id doaj.art-2e0de9e0c8474e8cb847dbcc3d5f489d
institution Directory Open Access Journal
issn 1179-1454
language English
last_indexed 2024-12-16T08:16:34Z
publishDate 2012-10-01
publisher Dove Medical Press
record_format Article
series Journal of Experimental Pharmacology
spelling doaj.art-2e0de9e0c8474e8cb847dbcc3d5f489d2022-12-21T22:38:13ZengDove Medical PressJournal of Experimental Pharmacology1179-14542012-10-012012default141148The therapeutic potential of RORγ modulators in the treatment of human diseaseChang MRGoswami DMercer BAGriffin PRMi Ra Chang,1 Devrishi Goswami,1 Becky A Mercer,2 Patrick R Griffin1,21Department of Molecular Therapeutics, Scripps Florida, The Scripps Research Institute, Jupiter, FL, USA; 2Translational Research Institute, Scripps Florida, The Scripps Research Institute, Jupiter, FL, USAAbstract: Nuclear receptors (NR) are ligand-regulated transcription factors that bind DNA in proximity to their target genes and exert their effects as a result of binding by small molecule ligands such as sterols, lipids, fatty acids, retinoids, and steroid hormones. The retinoic acid receptor-related orphan receptors or RORs (NR1F1–NR1F3) are nuclear receptors that regulate multiple cellular processes, including metabolism, cellular differentiation, and apoptosis, in a range of tissues and organs. These receptors bind as monomers to ROR response elements commonly called ROREs present in promoter regions of target genes and tether chromatin remodeling enzymes, facilitating recruitment of transcription machinery. Several recent reports have highlighted the potential role for RORs in human disease, and more importantly, studies have demonstrated that these receptors can be modulated by exogenous synthetic ligands, paving the way for development of novel therapeutics. Here we review the current status of synthetic ligand development as well as the structural aspects governing modulation of ROR signaling pathways as they relate to metabolic diseases and autoimmune disorders.Keywords: retinoic acid receptor-related orphan receptors (ROR), nuclear receptor (NR)modulator, synthetic ligand, inverse agonists, metabolic disorder, autoimmune disorder, ligand-binding domain (LBD)http://www.dovepress.com/the-therapeutic-potential-of-rorgamma-modulators-in-the-treatment-of-h-a11266
spellingShingle Chang MR
Goswami D
Mercer BA
Griffin PR
The therapeutic potential of RORγ modulators in the treatment of human disease
Journal of Experimental Pharmacology
title The therapeutic potential of RORγ modulators in the treatment of human disease
title_full The therapeutic potential of RORγ modulators in the treatment of human disease
title_fullStr The therapeutic potential of RORγ modulators in the treatment of human disease
title_full_unstemmed The therapeutic potential of RORγ modulators in the treatment of human disease
title_short The therapeutic potential of RORγ modulators in the treatment of human disease
title_sort therapeutic potential of ror amp gamma modulators in the treatment of human disease
url http://www.dovepress.com/the-therapeutic-potential-of-rorgamma-modulators-in-the-treatment-of-h-a11266
work_keys_str_mv AT changmr thetherapeuticpotentialofrorampgammamodulatorsinthetreatmentofhumandisease
AT goswamid thetherapeuticpotentialofrorampgammamodulatorsinthetreatmentofhumandisease
AT mercerba thetherapeuticpotentialofrorampgammamodulatorsinthetreatmentofhumandisease
AT griffinpr thetherapeuticpotentialofrorampgammamodulatorsinthetreatmentofhumandisease
AT changmr therapeuticpotentialofrorampgammamodulatorsinthetreatmentofhumandisease
AT goswamid therapeuticpotentialofrorampgammamodulatorsinthetreatmentofhumandisease
AT mercerba therapeuticpotentialofrorampgammamodulatorsinthetreatmentofhumandisease
AT griffinpr therapeuticpotentialofrorampgammamodulatorsinthetreatmentofhumandisease